Breakthrough Technology. Breakthrough Outcomes
The evidence is here.
A clinical study conducted at CHU Limoges, France demonstrated the clinical value of implementing a hospital-wide goal-directed therapy (GDT) protocol for blood and fluid management using Masimo noninvasive, continuous hemoglobin (SpHb®) and pleth variability index (PVi®) monitoring.
Watch the video to learn more. https://bit.ly/36B9T03